Compile Data Set for Download or QSAR
Found 190 of ec50 data for polymerid = 49001024,49001025,6290
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352489(CHEMBL1824052)copy SMILEScopy InChI
Affinity DataEC50:  0.230nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523757(US11136312, Compound MM-I-87)copy SMILES
Affinity DataEC50:  0.249nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523756(US11136312, Compound MM-I-83)copy SMILES
Affinity DataEC50:  0.276nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352480(CHEMBL1824051)copy SMILEScopy InChI
Affinity DataEC50:  0.350nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154508(CHEMBL3775042)copy SMILEScopy InChI
Affinity DataEC50:  0.460nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(MOUSE)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50021063(CHEMBL3287613)copy SMILEScopy InChI
Affinity DataEC50:  0.460nMAssay Description:Agonist activity at mouse SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021074(CHEMBL3287628)copy SMILEScopy InChI
Affinity DataEC50:  0.516nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352483(CHEMBL1824056)copy SMILEScopy InChI
Affinity DataEC50:  0.530nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523754(US11136312, Compound MM-I-66)copy SMILES
Affinity DataEC50:  0.585nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523801(US11136312, Compound SK-I-128)copy SMILES
Affinity DataEC50:  0.619nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM82547(SRIF-D-Trp8)copy SMILEScopy InChI
Affinity DataEC50:  0.630nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523770(US11136312, Compound SK-I-124)copy SMILES
Affinity DataEC50:  0.725nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM81767(15-28-Somatostatin-28 | CAS_38916-34-6 | CB6417646...)copy SMILEScopy InChI
Affinity DataEC50:  0.780nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352481(CHEMBL1824050)copy SMILEScopy InChI
Affinity DataEC50:  0.870nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50400517(CHEMBL2204935)copy SMILEScopy InChI
Affinity DataEC50:  0.950nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523803(US11136312, Compound SK-I-132)copy SMILES
Affinity DataEC50:  0.992nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523766(US11136312, Compound SK-I-57)copy SMILES
Affinity DataEC50:  1nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523760(US11136312, Compound SK-I-22)copy SMILES
Affinity DataEC50:  1.28nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021075(CHEMBL3287629)copy SMILEScopy InChI
Affinity DataEC50:  1.60nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523759(US11136312, Compound SK-I-16)copy SMILES
Affinity DataEC50:  1.76nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523762(US11136312, Compound SK-I-25)copy SMILES
Affinity DataEC50:  2.03nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50091557(CHEMBL3582317)copy SMILES
Affinity DataEC50:  2.5nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523758(US11136312, Compound MM-I-89)copy SMILES
Affinity DataEC50:  2.80nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021063(CHEMBL3287613)copy SMILEScopy InChI
Affinity DataEC50:  2.90nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523802(US11136312, Compound SK-I-130)copy SMILES
Affinity DataEC50:  3.09nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154509(CHEMBL3775387)copy SMILEScopy InChI
Affinity DataEC50:  3.10nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523767(US11136312, Compound SK-I-91)copy SMILES
Affinity DataEC50:  3.17nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154507(CHEMBL3775630)copy SMILEScopy InChI
Affinity DataEC50:  3.30nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523755(US11136312, Compound MM-I-72)copy SMILES
Affinity DataEC50:  3.32nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50136824((4R,7S,10S,13S,16R,19S,22S,25R)-16-((1H-indol-3-yl...)copy SMILEScopy InChI
Affinity DataEC50:  3.33nMAssay Description:Agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021090(CHEMBL3287632)copy SMILEScopy InChI
Affinity DataEC50:  3.70nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523742(US11136312, Compound SM-I-50)copy SMILES
Affinity DataEC50:  4.35nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021073(CHEMBL3287627)copy SMILEScopy InChI
Affinity DataEC50:  4.5nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50352482(CHEMBL1824055)copy SMILEScopy InChI
Affinity DataEC50:  4.70nMAssay Description:Partial agonist activity at human sst3 receptor expressed in CCL39 cells after 5 hrs by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7H1NPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154423(CHEMBL3774684)copy SMILEScopy InChI
Affinity DataEC50:  4.80nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50110470(CHEMBL3605798)copy SMILEScopy InChI
Affinity DataEC50:  5.20nMAssay Description:Agonist activity at human SSTR3 expressed in CHO cells assessed as intracellular cAMP level after 45 mins by time-resolved fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H9MPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154465(CHEMBL3775760)copy SMILEScopy InChI
Affinity DataEC50:  5.5nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523765(US11136312, Compound SK-I-56)copy SMILES
Affinity DataEC50:  5.63nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50400519(CHEMBL2204941)copy SMILEScopy InChI
Affinity DataEC50:  5.70nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523763(US11136312, Compound SK-I-53)copy SMILES
Affinity DataEC50:  5.97nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523764(US11136312, Compound SK-I-55)copy SMILES
Affinity DataEC50:  6.02nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523738(US11136312, Compound BN-VI-97)copy SMILES
Affinity DataEC50:  6.08nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50021064(CHEMBL3287614)copy SMILEScopy InChI
Affinity DataEC50:  6.10nMAssay Description:Agonist activity at human SST3 expressed in CHO-K1 cells assessed as foreskin-stimulated cAMP accumulation after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22N53V4PubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154521(CHEMBL3775532)copy SMILEScopy InChI
Affinity DataEC50:  6.40nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523768(US11136312, Compound SK-I-105)copy SMILES
Affinity DataEC50:  6.65nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523734(US11136312, Compound BN-VI-56)copy SMILES
Affinity DataEC50:  7.26nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM523761(US11136312, Compound SK-I-23)copy SMILES
Affinity DataEC50:  7.27nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2DB851BUS Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50154451(CHEMBL3775061)copy SMILEScopy InChI
Affinity DataEC50:  7.40nMAssay Description:Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levelsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZG6V4JPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)copy SMILES
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human SST3More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2183B4RPubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Salk Institute

Curated by ChEMBL
LigandPNGBDBM50110461(CHEMBL3605789)copy SMILEScopy InChI
Affinity DataEC50:  8.10nMAssay Description:Agonist activity at human SSTR3 expressed in CHO cells assessed as intracellular cAMP level after 45 mins by time-resolved fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29W0H9MPubMed
Displayed 1 to 50 (of 190 total ) | Next | Last >>
Jump to: